Glaxosmithkline Pharmaceuticals Limited v. Sanchem Life Sciences Pvt. Ltd. and Anr.
Case brief
What is this about?
Compromise decree under Order XXIII Rule 3 CPC; suit for permanent injunction decreed in terms of joint settlement application; GlaxoSmithKline Pharmaceuticals Limited v Sanchem Life Sciences Pvt. Ltd.; defendant permitted to exhaust existing stock within two months; monetary reliefs dismissed as not pressed; prayer 42(c) withdrawn with liberty; memorandum of settlement part of decree; interim orders merged; refund of 50% court fee within four weeks; Court Fees Act 1870 Sections 16 and 16-A; Section 89 CPC; CS(COMM) 547/2025; Delhi High Court; Justice Manmeet Pritam Singh Arora; decided 08.12.2025.
What did the court decide?
Joint compromise application allowed; suit decreed in favour of the plaintiff and against the defendant in terms of paragraph 2 of the application and prayer clauses 42(a), (b) and (e) of the plaint, with defendant to exhaust existing stock within two months; monetary prayers 42(d), (f), (g) dismissed as not pressed; prayer 42(c) disposed as withdrawn with liberty; 50% refund of court fee directed.